Grab your favorite coffee. This is where you’ll find all the substance you require, and more.

Cognivia-Narrow-Hero-1
Insights

Embracing Human Complexity in Clinical Research

As clinical trials become more diverse, patient heterogeneity, placebo responses, and inter-site variability become more pronounced, contributing to high rates of failed trials and extended development timelines…

Read More
Insights

A New Era of Cognivia

Innovation, evolution and agility have always been core elements of drug and device development. How else, but through creative, out-of-the-box thinking and a willingness to innovate have…

Read More
Insights

Innovation with Integrity

It has taken a decade of scientific integrity and rigor – and a very particular mindset – for Cognivia to develop its current suite of innovative solutions….

Read More
Publication

Prediction of the response to repetitive transcranial magnetic stimulation of the motor cortex in peripheral neuropathic pain and validation of a new algorithm

Abstract: Motor cortex repetitive transcranial magnetic stimulation (M1-rTMS) induces analgesic effects in neuropathic pain, but not all patients…

Type: Scientific Publication
Authors: Attal Nadine; Branders Samuel; Pereira Alvaro; Bouhassira Didier
Conference: The Journal of the International Association for the Study of Pain
Read More
Insights

Embracing Human Complexity in Clinical Research

As clinical trials become more diverse, patient heterogeneity, placebo responses, and inter-site variability become more pronounced, contributing to high rates of failed trials and extended development timelines…

Read More
Insights

Capturing Patients Diversity as the Next Challenge in Drug Development? Insights from IASP 2024 

Earlier this month, the IASP (International Association for the Study of Pain) meeting marked a significant moment in honoring the vision of Professor John Bonica founder of…

Read More
Webinars

Covariate Adjustment in Randomized Clinical Trials Based on Latest FDA Guidance: Application to Composite Covariates

In May 2023, the US Food and Drug Administration (FDA) released its final guidance titled “Adjusting for Covariates in Randomized Clinical Trials (RCT) for Drugs and Biological Products”. It is difficult to overstate the importance of this guidance as baseline covariate adjustment is an integral part of any statistical analysis of RCTs. Covariate…

Read More

Understand patient differences in your next clinical trial

Increase clinical trial success rates and get new therapies to patients faster.
Tell us about your clinical trial below and we'll be in touch.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.